SEC Form D · filed January 4, 2024
NovaBay Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Justin M. Hall · EMERYVILLE, CAExec · DirectorJulie Garlikov · EMERYVILLE, CADirectorStephen E. Butts · Chapel Hill, NCDirectorJorge E. Bartolome · Chapel Hill, NCDirectorHugh D. Evans · NEW YORK, NYDirectorJerry L. Whitmire · Tempe, AZDirectorYenyou (Jeff) E. Zheng · EMERYVILLE, CADirectorWilliam Burns · McKinney, TXExec · DirectorVincent A. Levien · Florham Park, NJExecSamuel Schreiber · Chilmark, MADirectorStephen Dalby · Lehi, UTDirectorSwan E. Sit · EMERYVILLE, CADirectorBhavika Vyas · New York, NYDirectorCato Partners GP, LLC · New York, NYDirectorJeff Siegel · Huntsville, UTExec · DirectorCato Partners Management, LLC · New York, NYDirectorJp A. Paquin · New York, NYDirectorPaul E. Freiman · EMERYVILLE, CADirectorDax T. Mitchell · Dallas, TXExecYongxiang (Sean) Zheng · EMERYVILLE, CADirectorvan Biema Value Partners, LLC · New York, NYDirectorTommy Law · EMERYVILLE, CAExecMijia (Bob) E. Wu · EMERYVILLE, CADirectorSteven M. Diedrich · Waco, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗